The second annual survey found that delays in authorization have decreased; at the same time, healthcare providers are calling for more transparent AI to reduce administrative burdens and preserve clinical judgment.
Boston, November 16, 2026 /PRNewswire/ — The clinical intelligence and operations platform for healthcare insurance plans, Cohere Health, today released the results of its “2026 National Pre-Authorization Healthcare Providers Survey.” The survey shows that due to delays in pre-authorization, there has been a significant decrease in patients abandoning treatment or turning to emergency care compared to last year. The survey also found that nearly all healthcare providers – including 96% of clinicians and 94% of office administrators – still trust the AI process in pre-authorization, but this trust is becoming more conditional as healthcare providers call for increased transparency, consistency, and manual oversight to reduce administrative burdens and to support timely healthcare services involving informed participation by clinicians.
Pre-authorization is a process in medical insurance plans that involves review before certain treatments are carried out. Its original intention was to support appropriate and evidence-based medical services, but it has now become one of the most administratively burdensome procedures within the healthcare system, often causing friction between insurance plans and healthcare providers. Despite ongoing efforts in the industry to modernize this process, surveys show that healthcare providers are still dealing with manual and opaque procedures that prevent them from focusing on patients and also affect their constantly changing relationships with AI.
"It is a meaningful progress that fewer patients are giving up treatment or ending up in the emergency room due to delays in pre-authorization," said Dr. Brian Covino, Chief Medical Officer of Cohere Health. "However, healthcare providers are still actively speaking up for patients who face medical barriers. They hope that AI can reduce manual work and speed up medical services, while still allowing clinical judgment and human supervision to remain the primary focus. We fully agree with this view: AI should never be used to deny medical care, but rather to help simplify administrative tasks so that healthcare providers can focus on making the most important decisions for patients."
The survey results show measurable improvements in the accessibility of medical services and outcomes related to delays. Among the 200 clinical doctors and office administrators surveyed, reports of patients abandoning recommended treatments due to authorization delays were approximately halved compared to the previous year: this proportion among doctors dropped from 55% to 28%. At the same time, there was also a reduction in reports of avoidable emergency visits or hospitalizations related to delays. Meanwhile, providers of medical services have become more cautious regarding AI; they believe that the most valuable AI is a AI that can handle routine administrative tasks and help to expedite the authorization process.
Although reports of health-related adverse consequences due to delays have decreased, pre-authorization still imposes a heavy administrative burden on healthcare providers who deal with this process every day: unclear documentation requirements and inconsistent procedures across different insurance plans lead to avoidable rejections when healthcare providers are unsure of what is needed and when it is required. Simply increasing automation will not alleviate this friction, nor will it win the trust of healthcare providers if the process itself remains unchanged.
This creates an opportunity to improve the experience for medical insurance plans: by simplifying work processes, clarifying requirements, and applying AI in a way that healthcare providers consider transparent, accountable, and trustworthy. Healthcare providers' expectations for AI go beyond pre-authorization; they hope for clearer rules, more comprehensive guidance, and they wish that AI can reduce administrative burdens while still preserving professional judgment. For medical insurance plans, pre-authorization is a natural starting point for building trust with healthcare providers and for establishing higher standards of collaboration throughout the organization; it also serves as a testing ground.
This survey was conducted in collaboration by Cohere Health and Wakefield Research, involving 200 clinical doctors and office administrators from hospitals and medical systems across the United States. For the full results, please refer to the latest white paper " Better AI , Not Less AI ", which is now available at www.coherehealth.com / thought-leadership / provider-ai-prior-authorization-survey.
About Cohere Health
Cohere Health indicates that its clinical intelligence and operational platform, along with solutions driven by the proxy AI, connect the strategic goals of medical insurance plans with the needs of healthcare providers, thereby optimizing the speed, cost, and quality of medical services. Through enterprise-level approaches, the company has simplified the decision-making processes for payers and service providers throughout the entire healthcare continuum – including policies, pre-authorization, payment accuracy, etc. – thus improving collaboration and reducing burdens, resulting in a return on investment of up to 9 times and a satisfaction rate of 94% among healthcare providers. Cohere Health has been selected for Time Magazine’s list of the top global health technology companies of 2026, the 2026 Inc 5000 list, and has been recognized by numerous industry analysts.
Media Contact
Brynn Spicher
anthonyBarnum Public Relations[ email protected ]Message source: Cohere Health












